Skip to main content
Erschienen in: Supportive Care in Cancer 1/2012

01.01.2012 | Original Article

Complementary and alternative medicine use among newly diagnosed prostate cancer patients

verfasst von: Cara L. McDermott, David K. Blough, Catherine R. Fedorenko, Neeraj K. Arora, Steven B. Zeliadt, Megan E. Fairweather, Ingrid Oakley-Girvan, Stephen K. Van Den Eeden, Scott D. Ramsey

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We surveyed prostate cancer patients about complementary and alternative medicine (CAM) use and evaluated patient factors that correlated with CAM use 6 months following diagnosis.

Methods

The Prostate CAncer Therapy Selection study was a prospective, observational multi-site study of men’s treatment decision-making process after a diagnosis of local stage prostate cancer. Recruitment occurred in community urology practices in Washington State, hospital-based urology clinics affiliated with the University of Southern California, and Kaiser Permanente in Northern California. Eligible study participants included men over age 21 diagnosed with local stage prostate cancer between May 1, 2005 and December 31, 2006.

Results

Fifty-two percent of survey respondents (379) reported using one or more types of CAM. Of the patients, 51% used one CAM method, 26% used two methods, and 23% used three or more methods. The most commonly reported category was mind–body therapies (65%). Only 43% of patients discussed their CAM use with a health professional; of those, 20% informed their primary care physician and 30% told the doctor managing their prostate cancer care. Less than half thought the CAM they used was “very helpful”, but a majority thought it was somewhat helpful for their condition.

Conclusions

Further research is needed to characterize the goals prostate cancer patients have for CAM, whether the treatments met those goals, and how this translates into the perceived helpfulness of these therapies. The implications of patients not discussing CAM use with health professionals at the time of prostate cancer treatment need further studies.
Literatur
1.
Zurück zum Zitat Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z et al (eds.) (2010) Seer cancer statistics review, 1975–2007, . National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010. Accessed 17 Sept 2010 Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z et al (eds.) (2010) Seer cancer statistics review, 1975–2007, . National Cancer Institute. Available at: http://​seer.​cancer.​gov/​csr/​1975_​2007/​, based on November 2009 SEER data submission, posted to the SEER web site, 2010. Accessed 17 Sept 2010
2.
Zurück zum Zitat Zeliadt SB, Potosky AL, Etzioni R, Ramsey SD, Penson DF (2004) Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER–Medicare trends 1991 to 1999. Urology 64(6):1171–1176PubMedCrossRef Zeliadt SB, Potosky AL, Etzioni R, Ramsey SD, Penson DF (2004) Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER–Medicare trends 1991 to 1999. Urology 64(6):1171–1176PubMedCrossRef
4.
Zurück zum Zitat Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL (2008) Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 148(6):435–448PubMed Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL (2008) Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 148(6):435–448PubMed
5.
Zurück zum Zitat Thompson I, Thrasher JB, Aus G, Burnett AL, Canby-Hagino ED, Cookson MS, D’Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus SR, Moul JW, Tangen CM (2007) Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 177(6):2106–2131PubMedCrossRef Thompson I, Thrasher JB, Aus G, Burnett AL, Canby-Hagino ED, Cookson MS, D’Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus SR, Moul JW, Tangen CM (2007) Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 177(6):2106–2131PubMedCrossRef
6.
Zurück zum Zitat Middleton RG, Thompson IM, Austenfeld MS, Cooner WH, Correa RJ, Gibbons RP, Miller HC, Oesterling JE, Resnick MI, Smalley SR et al (1995) Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer. The American Urological Association. J Urol 154(6):2144–2148PubMedCrossRef Middleton RG, Thompson IM, Austenfeld MS, Cooner WH, Correa RJ, Gibbons RP, Miller HC, Oesterling JE, Resnick MI, Smalley SR et al (1995) Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer. The American Urological Association. J Urol 154(6):2144–2148PubMedCrossRef
7.
Zurück zum Zitat Wasson JH, Cushman CC, Bruskewitz RC, Littenberg B, Mulley AG, Wennberg JE (1993) A structured literature review of treatment for localized prostate cancer. Prostate disease patient outcome research team. Arch Fam Med 2(5):487–493PubMedCrossRef Wasson JH, Cushman CC, Bruskewitz RC, Littenberg B, Mulley AG, Wennberg JE (1993) A structured literature review of treatment for localized prostate cancer. Prostate disease patient outcome research team. Arch Fam Med 2(5):487–493PubMedCrossRef
8.
Zurück zum Zitat Swarup AB, Barrett W, Jazieh AR (2006) The use of complementary and alternative medicine by cancer patients undergoing radiation therapy. Am J Clin Oncol 29(5):468–473PubMedCrossRef Swarup AB, Barrett W, Jazieh AR (2006) The use of complementary and alternative medicine by cancer patients undergoing radiation therapy. Am J Clin Oncol 29(5):468–473PubMedCrossRef
9.
Zurück zum Zitat Evans M, Shaw A, Thompson EA, Falk S, Turton P, Thompson T, Sharp D (2007) Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used. BMC Complement Altern Med 7:25PubMedCrossRef Evans M, Shaw A, Thompson EA, Falk S, Turton P, Thompson T, Sharp D (2007) Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used. BMC Complement Altern Med 7:25PubMedCrossRef
10.
Zurück zum Zitat Mansky PJ, Wallerstedt DB (2006) Complementary medicine in palliative care and cancer symptom management. Cancer J 12(5):425–431PubMedCrossRef Mansky PJ, Wallerstedt DB (2006) Complementary medicine in palliative care and cancer symptom management. Cancer J 12(5):425–431PubMedCrossRef
12.
Zurück zum Zitat Boon H, Brown JB, Gavin A, Westlake K (2003) Men with prostate cancer: making decisions about complementary/alternative medicine. Med Decis Mak 23(6):471–479CrossRef Boon H, Brown JB, Gavin A, Westlake K (2003) Men with prostate cancer: making decisions about complementary/alternative medicine. Med Decis Mak 23(6):471–479CrossRef
13.
Zurück zum Zitat Lippert MC, McClain R, Boyd JC, Theodorescu D (1999) Alternative medicine use in patients with localized prostate carcinoma treated with curative intent. Cancer 86(12):2642–2648PubMedCrossRef Lippert MC, McClain R, Boyd JC, Theodorescu D (1999) Alternative medicine use in patients with localized prostate carcinoma treated with curative intent. Cancer 86(12):2642–2648PubMedCrossRef
14.
Zurück zum Zitat Fasching PA, Thiel F, Nicolaisen-Murmann K, Rauh C, Engel J, Lux MP, Beckmann MW, Bani MR (2007) Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies. Support Care Cancer 15(11):1277–1284PubMedCrossRef Fasching PA, Thiel F, Nicolaisen-Murmann K, Rauh C, Engel J, Lux MP, Beckmann MW, Bani MR (2007) Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies. Support Care Cancer 15(11):1277–1284PubMedCrossRef
15.
Zurück zum Zitat Molassiotis A, Fernandez-Ortega P, Pud D, Ozden G, Platin N, Hummerston S, Scott JA, Panteli V, Gudmundsdottir G, Selvekerova S, Patiraki E, Kearney N (2005) Complementary and alternative medicine use in colorectal cancer patients in seven european countries. Complement Ther Med 13(4):251–257PubMedCrossRef Molassiotis A, Fernandez-Ortega P, Pud D, Ozden G, Platin N, Hummerston S, Scott JA, Panteli V, Gudmundsdottir G, Selvekerova S, Patiraki E, Kearney N (2005) Complementary and alternative medicine use in colorectal cancer patients in seven european countries. Complement Ther Med 13(4):251–257PubMedCrossRef
16.
Zurück zum Zitat Habermann TM, Thompson CA, LaPlant BR, Bauer BA, Janney CA, Clark MM, Rummans TA, Maurer MJ, Sloan JA, Geyer SM, Cerhan JR (2009) Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study. Am J Hematol 84(12):795–798PubMedCrossRef Habermann TM, Thompson CA, LaPlant BR, Bauer BA, Janney CA, Clark MM, Rummans TA, Maurer MJ, Sloan JA, Geyer SM, Cerhan JR (2009) Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study. Am J Hematol 84(12):795–798PubMedCrossRef
17.
Zurück zum Zitat Zeliadt SB, Ramsey SD, Potosky AL, Arora NK, Oakley-Girvan I, Hamilton AS, Van Den Eeden SK, Penson DF (2008) Association of pre-existing symptoms with treatment decisions among newly diagnosed prostate cancer patients. The Patient 1(3):189–200PubMed Zeliadt SB, Ramsey SD, Potosky AL, Arora NK, Oakley-Girvan I, Hamilton AS, Van Den Eeden SK, Penson DF (2008) Association of pre-existing symptoms with treatment decisions among newly diagnosed prostate cancer patients. The Patient 1(3):189–200PubMed
18.
Zurück zum Zitat Ramsey SD, Zeliadt SB, Arora NK, Blough DK, Penson DF, Oakley-Girvan I, Hamilton AS, Van Den Eeden SK, Fedorenko CR, Potosky AL (2010) Unanticipated and underappreciated outcomes during management of local stage prostate cancer: a prospective survey. J Urol 184(1):120–125PubMedCrossRef Ramsey SD, Zeliadt SB, Arora NK, Blough DK, Penson DF, Oakley-Girvan I, Hamilton AS, Van Den Eeden SK, Fedorenko CR, Potosky AL (2010) Unanticipated and underappreciated outcomes during management of local stage prostate cancer: a prospective survey. J Urol 184(1):120–125PubMedCrossRef
19.
Zurück zum Zitat Rose A, Peters N, Shea JA, Armstrong K (2004) Development and testing of the health care system distrust scale. J Gen Intern Med 19(1):57–63PubMedCrossRef Rose A, Peters N, Shea JA, Armstrong K (2004) Development and testing of the health care system distrust scale. J Gen Intern Med 19(1):57–63PubMedCrossRef
20.
Zurück zum Zitat Clark JA, Bokhour BG, Inui TS, Silliman RA, Talcott JA (2003) Measuring patients’ perceptions of the outcomes of treatment for early prostate cancer. Med Care 41(8):923–936PubMedCrossRef Clark JA, Bokhour BG, Inui TS, Silliman RA, Talcott JA (2003) Measuring patients’ perceptions of the outcomes of treatment for early prostate cancer. Med Care 41(8):923–936PubMedCrossRef
21.
Zurück zum Zitat Roth AJ, Rosenfeld B, Kornblith AB, Gibson C, Scher HI, Curley-Smart T, Holland JC, Breitbart W (2003) The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer. Cancer 97(11):2910–2918PubMedCrossRef Roth AJ, Rosenfeld B, Kornblith AB, Gibson C, Scher HI, Curley-Smart T, Holland JC, Breitbart W (2003) The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer. Cancer 97(11):2910–2918PubMedCrossRef
22.
Zurück zum Zitat Mehta SS, Lubeck DP, Pasta DJ, Litwin MS (2003) Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: results from CAPSURE. J Urol 170(5):1931–1933PubMedCrossRef Mehta SS, Lubeck DP, Pasta DJ, Litwin MS (2003) Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: results from CAPSURE. J Urol 170(5):1931–1933PubMedCrossRef
23.
Zurück zum Zitat Arora NK, Weaver KE, Clayman ML, Oakley-Girvan I, Potosky AL (2009) Physicians’ decision-making style and psychosocial outcomes among cancer survivors. Patient Educ Couns 77(3):404–412PubMedCrossRef Arora NK, Weaver KE, Clayman ML, Oakley-Girvan I, Potosky AL (2009) Physicians’ decision-making style and psychosocial outcomes among cancer survivors. Patient Educ Couns 77(3):404–412PubMedCrossRef
24.
Zurück zum Zitat Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG (2000) Development and validation of the expanded prostate cancer index composite (epic) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56(6):899–905PubMedCrossRef Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG (2000) Development and validation of the expanded prostate cancer index composite (epic) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56(6):899–905PubMedCrossRef
26.
Zurück zum Zitat Steenland K (2006) Personal communication of baseline and first follow-up questionnaires Steenland K (2006) Personal communication of baseline and first follow-up questionnaires
28.
Zurück zum Zitat D’Amico AV, Hui-Chen M, Renshaw AA, Sussman B, Roehl KA, Catalona WJ (2006) Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer. J Urol 176(6 Pt 2):S11–S15PubMedCrossRef D’Amico AV, Hui-Chen M, Renshaw AA, Sussman B, Roehl KA, Catalona WJ (2006) Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer. J Urol 176(6 Pt 2):S11–S15PubMedCrossRef
29.
Zurück zum Zitat Tippens K, Marsman K, Zwickey H (2009) Is prayer CAM? J Altern Complement Med 15(4):435–438PubMedCrossRef Tippens K, Marsman K, Zwickey H (2009) Is prayer CAM? J Altern Complement Med 15(4):435–438PubMedCrossRef
30.
Zurück zum Zitat Brown CM, Barner JC, Richards KM, Bohman TM (2007) Patterns of complementary and alternative medicine use in African Americans. J Altern Complement Med 13(7):751–758PubMedCrossRef Brown CM, Barner JC, Richards KM, Bohman TM (2007) Patterns of complementary and alternative medicine use in African Americans. J Altern Complement Med 13(7):751–758PubMedCrossRef
31.
Zurück zum Zitat Lee MM, Chang JS, Jacobs B, Wrensch MR (2002) Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations. Am J Public Health 92(10):1606–1609PubMedCrossRef Lee MM, Chang JS, Jacobs B, Wrensch MR (2002) Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations. Am J Public Health 92(10):1606–1609PubMedCrossRef
32.
Zurück zum Zitat Eng J, Ramsum D, Verhoef M, Guns E, Davison J, Gallagher R (2003) A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer. Integr Cancer Ther 2(3):212–216PubMedCrossRef Eng J, Ramsum D, Verhoef M, Guns E, Davison J, Gallagher R (2003) A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer. Integr Cancer Ther 2(3):212–216PubMedCrossRef
33.
Zurück zum Zitat Jones RA, Taylor AG, Bourguignon C, Steeves R, Fraser G, Lippert M, Theodorescu D, Mathews H, Kilbridge KL (2007) Complementary and alternative medicine modality use and beliefs among African American prostate cancer survivors. Oncol Nurs Forum 34(2):359–364PubMedCrossRef Jones RA, Taylor AG, Bourguignon C, Steeves R, Fraser G, Lippert M, Theodorescu D, Mathews H, Kilbridge KL (2007) Complementary and alternative medicine modality use and beliefs among African American prostate cancer survivors. Oncol Nurs Forum 34(2):359–364PubMedCrossRef
34.
Zurück zum Zitat Bausell RB, Lee WL, Berman BM (2001) Demographic and health-related correlates to visits to complementary and alternative medical providers. Med Care 39(2):190–196PubMedCrossRef Bausell RB, Lee WL, Berman BM (2001) Demographic and health-related correlates to visits to complementary and alternative medical providers. Med Care 39(2):190–196PubMedCrossRef
35.
Zurück zum Zitat Carpenter CL, Ganz PA, Bernstein L (2009) Complementary and alternative therapies among very long-term breast cancer survivors. Breast Cancer Res Treat 116(2):387–396PubMedCrossRef Carpenter CL, Ganz PA, Bernstein L (2009) Complementary and alternative therapies among very long-term breast cancer survivors. Breast Cancer Res Treat 116(2):387–396PubMedCrossRef
36.
Zurück zum Zitat Diefenbach MA, Hamrick N, Uzzo R, Pollack A, Horwitz E, Greenberg R, Engstrom PF (2003) Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer. J Urol 170(1):166–169PubMedCrossRef Diefenbach MA, Hamrick N, Uzzo R, Pollack A, Horwitz E, Greenberg R, Engstrom PF (2003) Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer. J Urol 170(1):166–169PubMedCrossRef
37.
Zurück zum Zitat Roberts CS, Baker F, Hann D, Runfola J, Witt C, McDonald J, Livingston ML, Ruiterman J, Ampela R, Kaw OC, Blanchard C (2005) Patient–physician communication regarding use of complementary therapies during cancer treatment. J Psychosoc Oncol 23(4):35–60PubMedCrossRef Roberts CS, Baker F, Hann D, Runfola J, Witt C, McDonald J, Livingston ML, Ruiterman J, Ampela R, Kaw OC, Blanchard C (2005) Patient–physician communication regarding use of complementary therapies during cancer treatment. J Psychosoc Oncol 23(4):35–60PubMedCrossRef
38.
Zurück zum Zitat Wilkinson S, Farrelly S, Low J, Chakraborty A, Williams R (2008) The use of complementary therapy by men with prostate cancer in the UK. Eur J Cancer Care (Engl) 17(5):492–499CrossRef Wilkinson S, Farrelly S, Low J, Chakraborty A, Williams R (2008) The use of complementary therapy by men with prostate cancer in the UK. Eur J Cancer Care (Engl) 17(5):492–499CrossRef
Metadaten
Titel
Complementary and alternative medicine use among newly diagnosed prostate cancer patients
verfasst von
Cara L. McDermott
David K. Blough
Catherine R. Fedorenko
Neeraj K. Arora
Steven B. Zeliadt
Megan E. Fairweather
Ingrid Oakley-Girvan
Stephen K. Van Den Eeden
Scott D. Ramsey
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2012
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-010-1055-y

Weitere Artikel der Ausgabe 1/2012

Supportive Care in Cancer 1/2012 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.